Author: Kate Ward

An Obstetric Cardiology Meeting is planned for 11 October 2023 at Ko Awatea, Middlemore Hospital, Auckland. The audience for the meeting included cardiologists, obstetric physicians, maternal medicine specialists, maternal fetal medicine specialists, anaesthetists with an interest in obstetrics, midwives, fellows, and registrars in training. Here is a copy of the programme with registration details.

The NZ Cardiac Medal was awarded to Fiona Riddell at the Annual Scientific Meeting in Auckland in 2023 Fiona began Cardiac Physiology training in 1978 at Green Lane Hospital where the field of pacemakers grabbed her attention from a very early stage. Those were the days of oscilloscope measurement of pacemaker data and no programmability. She was the Charge Cardiac Physiologist […]

Congratulations to Australian colleagues: CSANZ immediate past president Professor Clara Chow, and Professor Gemma Figtree FCSANZ, who were awarded ‘Member of the Order of Australia’ in the 2023 Australia Day Awards. Read more here.

After undertaking some consumer research, the Heart Foundation has updated its heart failure resources creating: a new heart failure action plan, a new resource for people supporting whānau with heart failure   a pack that pulls our resources together in one place. There’s a new heart failure hub on their website, which includes videos on heart failure management and personal […]

Congratulations to New Zealand Waikato-based Fellow of the Society Dr Martin Stiles who is the new Chair of the CSANZ Scientific Committee. Dr Martin Stiles convened the Scientific Program for this year’s CSANZ 70th Annual Scientific Meeting in Gold Coast. The meeting was organised by a New Zealand group lead by Dr Mayanna Lund and Dr Stiles. You can read […]

… and the winner is… New Zealand Cardiac Society member Dr Keriana Kingi-Nepe! Dr Kingi-Nepe presented the findings of a study titled The Impact of Sacubitril-Valsartan (S-V) on Te Tairāwhiti (Gisborne and East Coast) Region. You can read the abstract in the Heart Lung and Circulation journal here. Warmest congratulations and thanks to you Keriana, and to your fellow investigators, […]

To read the 2021 NZ CSANZ Position Statement on lipid treatment targets in individuals at high cardiovascular risk, please click here.

‘Heart’ October 22, 2021 Heart failure and cardiomyopathies Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006–2018 Daniel Z L Chan, Andrew Kerr, Corina Grey, Vanessa Selak, Mildred Ai Wei Lee, Mayanna Lund, Katrina Poppe, Rob N Doughty doi: 10.1136/heartjnl-2021-319853 BMC Cardiovascular Disorders October 24, 2021 Winter-Smith J, Selak V, Harwood M, Ameratunga S, Grey C. […]

On 7 September 2021, Pharmac announced that it had secured ongoing supply of the following medicines used in the treatment of various cardiovascular conditions: furosemide 40 mg tablets metoprolol tartrate 50 mg and 100 mg tablets propranolol 10 mg and 40 mg tablets Read the details of the consultation and decision on the Pharmac website.

A collaboration between ASH NZ, the Heart Foundation, Hāpai te Hauora, Tala Pasifika and Pacific Heartbeat aims to improve heart health outcomes and reduce inequalities. Find out more on the ASH NZ website here.